Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
International Genomics Consortium (IGC) is a leading non-profit biorepository and biosciences research entity specializing in collecting and processing biospecimens for cancer and complex disease genomics research. IGC played a foundational role in The Cancer Genome Atlas (TCGA), providing standardized tissue samples and data to accelerate cancer biomarker discovery and therapeutics development. IGC does not directly sponsor therapeutic clinical trials but enables translational research through high-quality biospecimens and genomic data.[5][8]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on International Genomics Consortium.